Result of general meeting

November 22, 2024 biodexa pharmaceuticals plc (“biodexa” or the “company”) result of general meeting biodexa pharmaceuticals plc (“biodexa” or the “company”) (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces, announces that at its general meeting held earlier today, both resolutions put to the company's shareholders were duly passed. the full text of, inter alia, the resolutions proposed and passed at the annual general meeting and general meeting can be found in the notice of the general meeting on the company's website at: https://biodexapharma.com/investors/corporate-governance/#agms.
GM Ratings Summary
GM Quant Ranking